Dale Stafford
Partner,
About Dale
Expertise
Dale Stafford is a member of our Mergers & Acquisitions and Healthcare and Life Sciences practices. He has more than 20 years of management consulting experience, advising leading companies on their biggest challenges and opportunities.
Dale has led successful merger integrations in a variety of industries, including medical technology, pharmaceuticals, airlines, transportation, professional services, wholesale distribution, telecommunications, cable, software and consumer products. In addition, he has extensive experience developing growth strategies to help providers, insurers, life sciences, and healthcare technology companies outperform.
Prior to joining Bain, Dale worked in strategy at Coca-Cola Enterprises. He started his career as a designer/developer of software for healthcare companies.
Dale studied business strategy at the Leipzig School of Management in Germany and earned an MBA at Emory University, where he was a Woodruff Scholar. He graduated summa cum laude from the University of Mississippi with a Bachelor of Science in mathematics.
Bain partner Dale Stafford discusses "Integrating cultures after a merger."
Recent Insights
- “How Companies Got So Good at M&A ,” Brief, April 2024
- “Key Insights from Bain’s 2024 M&A Report,” Webinar, February 2024
- “Regulation and M&A: How Scrutiny Raises the Bar for Acquirers ,” M&A Report, January 2024, Report
- “Looking Back at M&A in 2023: Who Wins in a Down Year?,” M&A Report, January 2024, Report
- “Looking Ahead: How the Big Backlog Will Shape the 2024 M&A Agenda,” M&A Report, January 2024, Report
In the News
- “Health-care companies are on a deal spree and aren't likely to stop anytime soon,” CNBC, April 2018, Healthcare & Life Sciences
- “China Moves a Step Forward in Its Quest for Food Security ,” New York Times, April 2017, Financial Services
- “Dale Stafford on the State of M&A in Healthcare,” Bloomberg, March 2017, Financial Services
- “When mergers fail because of clashing work culture,” Marketplace, May 2016
- “M&A Boom Goes Bust on Regulatory Uncertainty,” Bloomberg TV, May 2016